NEVRO CORP's ticker is and the CUSIP is 64157FAC7. A total of 25 filers reported holding NEVRO CORP in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $203,040,000 | +60.8% | 18,000,000 | +100.0% | 1.57% | -14.6% |
Q3 2021 | $126,234,000 | -59.6% | 9,000,000 | -50.0% | 1.83% | -9.7% |
Q2 2021 | $312,552,000 | +131.0% | 18,000,000 | +100.0% | 2.03% | +18.6% |
Q1 2021 | $135,324,000 | -18.2% | 9,000,000 | 0.0% | 1.71% | -3.6% |
Q4 2020 | $165,420,000 | +16.6% | 9,000,000 | 0.0% | 1.78% | -14.3% |
Q3 2020 | $141,822,000 | +16.7% | 9,000,000 | 0.0% | 2.07% | +5.2% |
Q2 2020 | $121,500,000 | – | 9,000,000 | – | 1.97% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Myriad Asset Management Ltd. | 10,000,000 | $15,644,000 | 3.40% |
Perceptive Advisors | 9,000,000 | $141,822,000 | 2.07% |
DeepCurrents Investment Group LLC | 14,430,000 | $22,483,000 | 0.76% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 12,000,000 | $18,784,000 | 0.46% |
Polar Asset Management Partners Inc. | 17,500,000 | $27,302,000 | 0.37% |
ZAZOVE ASSOCIATES LLC | 1,320,000 | $2,063,000 | 0.27% |
WOLVERINE ASSET MANAGEMENT LLC | 16,000,000 | $24,947,000 | 0.22% |
Context Capital Management, LLC | 500,000 | $768,000 | 0.17% |
Context Partners Fund, L.P. | 500,000 | $768,000 | 0.17% |
PFM Health Sciences, LP | 2,000,000 | $3,151,000 | 0.15% |